Connect with us

Hi, what are you looking for?


Components Player Invests £2.5m in Radiology Firm Adaptix

Avingtrans, which designs, manufactures, and supplies critical components, modules, systems has invested £2.5 million in a £12.9 million fund raise by emerging Oxford-based medtech firm, Adaptix.

Components Player Invests £2.5m in Radiology Firm Adaptix

Adaptix’s focus is on transforming radiology by allowing low-cost, low-dose 3D portable imaging. It has developed several novel technologies and imaging approaches in relation to Digital Tomosynthesis (DT). At the core of Adaptix’s technology is the ‘Flat Panel X-ray Source’ (FPS) which consists of a monoblock containing an array of individually controlled X-ray emitters combined with a high-voltage power supply.

In return for its investment, Avingtrans will own approximately 5.9% of the total issued share capital of Adaptix, post the closing of the fund raise.

Avingtrans intends to collaborate with Adaptix through its majority owned-subsidiary Magnetica to develop a disruptive business offering. This will bring together low-cost 3D imaging – in the form of Magnetica’s Cryogen-free MRI and Adaptix’s DT – to allow fusing of image data, creating an enhanced, low-cost diagnostic capability, initially for orthopaedic imaging.

The collaboration will ultimately bring together low-cost 3D MRI, X-ray and potentially ultrasound, creating a solution that can address a significant proportion of all medical and veterinary imaging procedures, with target markets including some 28,000 US sites focused on minor injuries (urgent care) and private orthopaedic practices (private practices and ambulatory surgical centres).

Mark Evans, CEO of Adaptix, said: “Our vision is to offer multi-modal 3D imaging to under-served medical markets in major economies focussed on extremity imaging, which will be driven by a ‘pay-per-Study’ business model. Our competitive advantage will be facilitated by: the low cost of the equipment, protected and enabled by proprietary technology; equipment that does not need high-cost rooms and installation; and portability that enables equipment to be cheaply redeployed and therefore, facilitates new service models. We believe that by working with Avingtrans and Magnetica, we will be able to deliver a unique proposition to the medical imaging market.”

Steve McQuillan, CEO of Avingtrans, added: “We are excited by the prospect of Magnetica working with the team at Adaptix, to our mutual benefit. As fellow travellers on parallel disruptive medical imaging paths, we believe that working together will deliver cost and market synergies for both businesses to enhance potential shareholder value, through better quality and flexible multi-modal imaging, enhancing the end customer experience.”

Seen on Med-Tech Innovation News: Article Link

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News


PocDoc, the digital health platform and personal diagnostics provider, has launched what it says is a world-first smartphone-based test for cardiovascular disease.


Focused on connecting startups in the Medtech industry with potential investors, this can't miss event features the globe's most promising companies


The technology could greatly aid spinal surgeons in planning surgical interventions in advance.   


Emerging HealthTech company, Stasis Labs, Inc. intends to bridge the gap between clinicians and their patients with an all-in-one FDA-cleared hardware and software solution,...

You May Also Like


Today & Tomorrow: Digital Solutions in HealthTech Plug “digital healthcare solutions” into Google, and the results are clear: digital tools have taken the healthcare...


In Delray Beach, Florida, an emerging biopharma company, Cyrano Therapeutics, is planning a clinical trial using approved theophylline via a new intranasal pathway of...


Software as a Medical Device (SaMD) is driving innovation in the HealthTech space and is more popular than ever — completely upending the way...


The sky’s the limit for HealthTech PR and looking past traditional strategies to nontraditional avenues for engagement will allow agencies to stand out.